🇺🇸 FDA
Patent

US 11197923

Methods and compositions for live attenuated viruses

granted A61KA61K2039/5254A61K2039/55555

Quick answer

US patent 11197923 (Methods and compositions for live attenuated viruses) held by Takeda Vaccines, Inc. expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Vaccines, Inc.
Grant date
Tue Dec 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K2039/5254, A61K2039/55555, A61K2039/70, A61K39/12